Walter Eisner The FDA’s Orthopaedic and Rehabilitation Devices Panel will meet on April 20, 2016 to discuss, make recommendations, and vote on the premarket approval application (PMA) for the Cartiva Synthetic Cartilage Implant (SCI), sponsored by Cartiva, Inc. Cartiva’s implant is an organic polymer-based biomaterial to mimic biologic cartilage. The device, according to an FDA […]